Conference

Avenna at SEHTA Conference

Avenna at SEHTA Conference              In this video, we explain Avenna’s core technology, GlyHealth. We explain the current four variants in our development pipeline including, GlyHealth-Index, IBD, SCI, and COVID-19, and expand on GlyHealth-Index and IBD. This video also compares conventional vs glycomic biomarkers for early detection and treatment personalisation …

Avenna at SEHTA Conference Read More »

https://www.linkedin.com/posts/avenna-ltd_glycans-are-crucial-in-covid-19-infection-activity-6785481637766414336-4xrj

WuXi HealthCare forum presentation

WuXi HealthCare forum presentation In this video, we explain Avenna’s core technology, GlyHealth. We explain the current four variants in our development pipeline including, GlyHealth-Index, IBD, SCI, and COVID-19, and expand on GlyHealth-Index and IBD. This video also compares conventional vs glycomic biomarkers for early detection and treatment personalisation of inflammatory disease. Click here to see …

WuXi HealthCare forum presentation Read More »

Avenna at NOAH Conference

Avenna at NOAH Conference 2019        This is a recording of our presentation at this renown tech conference. Our CEO discusses the burden of chronic inflammatory diseases (CIDs) and limitations in CIDs diagnostic procedures. Additionally, this presentation explains how Avenna medical technology can reliably detect and predict future CIDs using molecular signals from …

Avenna at NOAH Conference Read More »